Technical analysis of CVRx, Inc. (CVRX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure.
Price Performance
| 1 month | +9.82% |
| 3 months | -38.99% |
| Year-to-date | -57.46% |
| 1 year | -55.46% |
| 3 years | -80.14% |
| 5 years | -80.09% |
52-Week Range
| 52-week High | $11.30 |
| 52-week Low | $2.20 |
| Avg Volume (90d) | 667K |
Technical Indicators
| SMA 50 | $3.92 |
| SMA 200 | $6.28 |
| Beta | 1.12 |
| 30-day Volatility (annualised) | 272.2% |
| Price vs SMA 50 | -22.9% |
| Price vs SMA 200 | -51.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $10.19 | |
| 2025-11 | $9.81 | -3.7% |
| 2025-12 | $7.10 | -27.6% |
| 2026-01 | $6.85 | -3.5% |
| 2026-02 | $8.16 | +19.1% |
| 2026-03 | $9.46 | +15.9% |
| 2026-04 | $7.51 | -20.6% |
| 2026-05 | $5.58 | -25.7% |
| 2026-06 | $5.14 | -7.9% |
| 2026-07 | $5.18 | +0.8% |
| 2026-08 | $2.96 | -42.9% |
| 2026-09 | $3.02 | +2.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $3.02 |
| Market Cap | $80M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.99 |
| EV / EBITDA | -1.68 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 2.98 |
| Current Ratio | 8.04 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -6.26 |